Drug Profile
Research programme: antiviral vaccines - Immunotope
Alternative Names: Viral haemorrhagic fever vaccine - ImmunotopeLatest Information Update: 28 Oct 2018
Price :
$50
*
At a glance
- Originator Immunotope
- Class Dengue vaccines; Viral vaccines
- Mechanism of Action Cytotoxic T lymphocyte stimulants; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Dengue; Hepatitis B; Hepatitis C; HIV infections; Influenza virus infections; Viral haemorrhagic fevers
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for preclinical development in Dengue(Prevention) in USA
- 28 Oct 2018 No recent reports of development identified for preclinical development in Hepatitis-B in USA
- 28 Oct 2018 No recent reports of development identified for preclinical development in Hepatitis-C in USA